Nurostar C 1 Injection is a parenteral formulation combining Folic Acid (0.7 mg), Methylcobalamin (1500 mcg), and Niacinamide (12 mg), designed to address various vitamin deficiencies and support neurological and hematological health. Folic Acid, a vital B-vitamin, plays a critical role in DNA synthesis, red blood cell formation, and prevention of megaloblastic anemia. Methylcobalamin, the active form of Vitamin B12, is essential for nerve cell maintenance, myelin sheath formation, and effective neurological function, making it beneficial in treating peripheral neuropathies and vitamin B12 deficiency. Niacinamide, a form of Vitamin B3, contributes to energy metabolism, skin health, and has anti-inflammatory properties. The combination in Nurostar C 1 Injection offers synergistic effects, enhancing hematopoiesis and nerve regeneration, thus making it suitable for patients with nutritional deficiencies, neuropathies, or those requiring vitamin supplementation due to malabsorption or chronic illnesses. This injectable preparation ensures rapid bioavailability and is typically administered under medical supervision. Contraindications include hypersensitivity to any component, and caution is advised in patients with renal or hepatic impairment. Adverse effects are generally rare but may include local injection site reactions or mild gastrointestinal disturbances. Nurostar C 1 Injection should be used as part of a comprehensive treatment plan tailored to individual patient needs.